Literature DB >> 6337097

Adherence of group A streptococci to fibronectin on oral epithelial cells.

W A Simpson, E H Beachey.   

Abstract

The possibility that fibronectin on the surface of oropharyngeal cells may serve as a receptor for the binding of group A streptococci (Streptococcus pyogenes) was investigated. Purified human plasma fibronectin inhibited the adherence of group A streptococci to oral epithelial cells in a dose-dependent manner. The relative amounts of fibronectin available on oral epithelial cells correlated closely with the ability of these cells to bind streptococci. Group A streptococci agglutinated latex beads containing covalently linked fibronectin on their surface, and this agglutination could be inhibited by lipoteichoic acid, the adhesion that mediates attachment of group A streptococci to epithelial cells. Gelatin and the alpha 1 chain of type I collagen partially inhibited both the adherence of streptococci to oral epithelial cells and the binding of radiolabeled fibronectin to streptococci; however, the purified fibronectin-binding peptide of collagen, alpha 1 (I)CB7, inhibited neither. The binding of radiolabeled fibronectin to streptococci was inhibited by lipoteichoic acid. These results suggest that fibronectin on oral epithelial cells serves as a lipoteichoic acid-sensitive receptor for group A streptococci.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337097      PMCID: PMC347937          DOI: 10.1128/iai.39.1.275-279.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  LETS protein in normal and pathological human oral epithelium.

Authors:  B R Zetter; T E Daniels; C Quadra-White; J S Greenspan
Journal:  J Dent Res       Date:  1979-01       Impact factor: 6.116

Review 2.  Fibronectin: a review of its structure and biological activity.

Authors:  E Pearlstein; L I Gold; A Garcia-Pardo
Journal:  Mol Cell Biochem       Date:  1980-02-08       Impact factor: 3.396

3.  Fibronectin binds to Staphylococcus aureus.

Authors:  P Kuusela
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

4.  Fibronectin and proteoglycans as determinants of cell-substratum adhesion.

Authors:  L A Culp; B A Murray; B J Rollins
Journal:  J Supramol Struct       Date:  1979

5.  Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma.

Authors:  N E Stathakis; M W Mosesson
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

6.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

7.  Characteristics of the binding of streptococcal lipoteichoic acid to human oral epithelial cells.

Authors:  W A Simpson; I Ofek; C Sarasohn; J C Morrison; E H Beachey
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

8.  Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes.

Authors:  W A Simpson; D L Hasty; J M Mason; E H Beachey
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  Binding of streptococcal lipoteichoic acid to the fatty acid binding sites on serum albumin.

Authors:  W A Simpson; I Ofek; E H Beachey
Journal:  J Biol Chem       Date:  1980-07-10       Impact factor: 5.157

10.  Distribution of a major connective tissue protein, fibronectin, in normal human tissues.

Authors:  S Stenman; A Vaheri
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  65 in total

1.  Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding.

Authors:  Christiane Beckmann; Joshua D Waggoner; Theresa O Harris; Glen S Tamura; Craig E Rubens
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Bacterial infection of wounds: fibronectin-mediated adherence group A and C streptococci to fibrin thrombi in vitro.

Authors:  G S Chhatwal; P Valentin-Weigand; K N Timmis
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Role of M protein in adherence of group A streptococci.

Authors:  M G Caparon; D S Stephens; A Olsén; J R Scott
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

4.  Differential effects of the streptococcal fibronectin-binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and HEp-2 tissue culture cells.

Authors:  H S Courtney; J B Dale; D I Hasty
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides.

Authors:  C Signäs; G Raucci; K Jönsson; P E Lindgren; G M Anantharamaiah; M Höök; M Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 6.  Multiple adhesins of streptococci.

Authors:  D L Hasty; I Ofek; H S Courtney; R J Doyle
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

7.  Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells.

Authors:  S T Pottratz; W J Martin
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

8.  Bacteria: a major pathogenic factor for anastomotic insufficiency.

Authors:  H M Schardey; T Kamps; H G Rau; S Gatermann; G Baretton; F W Schildberg
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

9.  Interactions of fibronectin with Treponema pallidum.

Authors:  T J Fitzgerald; L A Repesh
Journal:  Genitourin Med       Date:  1985-06

10.  Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria.

Authors:  G M Vercellotti; J B McCarthy; P Lindholm; P K Peterson; H S Jacob; L T Furcht
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.